Form 4: Medtronic Officer Sells Shares for Tax Obligations

Medtronic's Chief Accounting Officer, Denise L. Blomquist, disposed of 148 ordinary shares to cover tax liabilities related to vested restricted stock units.

Summary

• Denise L. Blomquist, Medtronic's Chief Accounting Officer, reported a transaction on January 29, 2026.
• She disposed of 148 ordinary shares at a price of $101 per share.
• This disposition was for the payment of taxes upon the vesting of previously reported restricted stock units.
• Following this transaction, Blomquist beneficially owns 12,306 ordinary shares.
• Her total beneficial ownership includes 97 shares acquired through dividend reinvestment since her last report.
• The transaction was executed under a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation and tax planning, and not indicative of a change in company fundamentals or insider sentiment.

Positives

• The transaction was for tax withholding, not a discretionary sale, indicating a non-negative reason for disposition.
• The reporting person's beneficial ownership increased by 97 shares through dividend reinvestment, showing continued investment in the company.

Negatives

• A disposition of shares, even for tax purposes, reduces the insider's direct holding.

Future Outlook

No specific future outlook or guidance is provided in this Form 4, as it primarily reports a past insider transaction.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those for tax withholding upon RSU vesting, are common across all industries, particularly for executives receiving equity compensation. These transactions typically do not reflect a change in management's outlook on the company's performance but rather a standard compensation and tax event.

Comparison to Industry Standards

• StockSavvy.ai observes that the use of Rule 10b5-1(c) plans for such transactions is a standard corporate governance practice among publicly traded companies, including peers in the medical technology sector like Johnson & Johnson (JNJ) or Abbott Laboratories (ABT), to mitigate concerns about insider trading and ensure compliance with SEC regulations.
• The disposition of shares for tax purposes is also a common occurrence when restricted stock units vest, aligning with typical executive compensation structures across global benchmarks.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax-related transaction, not a discretionary sale, and does not signal a change in company fundamentals.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of restricted stock units. Such transactions are common and generally do not signal a change in the company's fundamental outlook or warrant a shift in investment strategy. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an existing investment thesis.

Keywords

Medtronic, MDT, SEC Form 4, Insider Trading, Beneficial Ownership, Stock Transaction, Restricted Stock Units, Tax Withholding, Denise L. Blomquist, Chief Accounting Officer, Dividend Reinvestment